Amanda Sheppeard

A simple clinical score may help rule out deep laryngeal involvement in pemphigus vulgaris and reduce unnecessary laryngoscopy.

A large population analysis has found no clinically meaningful reduction in adult height among teenagers treated with isotretinoin, despite longstanding concerns over premature growth plate closure.

Social media, biologic therapies and improved education are helping shift awareness of hidradenitis suppurativa – but there is still much to be done.

Experts and advocates have welcomed the landmark biologic that potentially delays the need for insulin by multiple years.

Australia is hundreds of rheumatologists short of demand, with workforce burnout, training bottlenecks and rising chronic disease driving a worsening access crisis.

Women experiencing abuse are being retraumatised by the systems meant to protect them, says psychiatrist Dr Karen Williams.

And researchers warn that warned that even low-to-moderate drinking carries measurable risks across cancer, cardiovascular disease, dementia and liver disease.

Experts say postcode remains a major factor in access to timely diagnosis, treatment and ongoing support.

New trial data shows reducing tirzepatide can preserve much of the weight loss benefit, but staying on the maximum tolerated dose remains most effective.

Less than 15% of high-risk Australians are up to date with covid boosters, despite a record flu season and growing concern over RSV in older and immunocompromised patients, the ARA's ASM has been told.